top of page
Browse by category
Search
Rice's Biotech Launch Pad to lead commercialisation of ROGUE implant for treating obesity
Rice University's Biotech Launch Pad will lead the commercialization effort for "Rx On-site Generation Using Electronics" (ROGUE), a...
NeuroBo reveals DA-1726 safe and well tolerated
NeuroBo Pharmaceuticals has revealed positive top-line safety, tolerability and dose-linear pharmacokinetics (PK) data from the single...
Proposed bariatric medical tourism discharge checklist to improve the safety for patients
In a recent article, ‘Medical Tourism: “Discharge Planning Safety Checklist” for Safe Follow-Up and Outcomes for Our Patients’, published...
LSG with Nissen Fundoplication has higher prevalence of comorbidities and a longer hospital length of stay
Patients who underwent laparoscopic sleeve gastrectomy (LSG) with Nissen Fundoplication (NF) had a higher prevalence of comorbidities and...
Journal watch 2/10/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
EndoZip Endoscopic Suturing System results in an average TBWL of 13.21% at 12 months
The outcomes from a multi-centre study have revealed the effectiveness of the EndoZip system in achieving significant weight loss, with...
Browse by tag
bottom of page